Dr. Martens plc (LON:DOCS) Insider Jon Mortimore Purchases 97 Shares

Dr. Martens plc (LON:DOCS – Get Free Report) insider Jon Mortimore purchased 97 shares of the firm’s stock in a transaction dated Friday, August 11th. The shares were purchased at an average cost of GBX 154 ($1.95) per share, for a total transaction of £149.38 ($189.50).

Jon Mortimore also recently made the following trade(s):

Get Dr. Martens alerts:

• On Tuesday, July 11th, Jon Mortimore purchased 119 shares of Dr. Martens stock. The shares were purchased at an average cost of GBX 126 ($1.60) per share, for a total transaction of £149.94 ($190.21).
• On Monday, June 12th, Jon Mortimore bought 116 shares of Dr. Martens stock. The stock was bought at an average cost of GBX 130 ($1.65) per share, for a total transaction of £150.80 ($191.30).

Dr. Martens Trading Up 1.3 %

LON:DOCS opened at GBX 154.40 ($1.96) on Tuesday. The business has a fifty day moving average of GBX 133.83 and a 200-day moving average of GBX 146.76. Dr. Martens plc has a 1 year low of GBX 113 ($1.43) and a 1 year high of GBX 295.21 ($3.74). The stock has a market cap of £1.54 billion, a price-to-earnings ratio of 1,187.69, a PEG ratio of 0.04 and a beta of -0.02. The company has a debt-to-equity ratio of 110.29, a quick ratio of 1.13 and a current ratio of 3.09.

Dr. Martens Increases Dividend

The business also recently declared a dividend, which was paid on Tuesday, July 18th. Investors of record on Thursday, June 8th were given a GBX 4.28 ($0.05) dividend. This is a positive change from Dr. Martens’s previous dividend of $1.56. The ex-dividend date of this dividend was Thursday, June 8th. This represents a dividend yield of 2.74%. Dr. Martens’s dividend payout ratio (DPR) is 4,615.38%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on DOCS. Barclays reaffirmed an “overweight” rating and issued a GBX 175 ($2.22) target price on shares of Dr. Martens in a research note on Monday, June 5th. Royal Bank of Canada cut Dr. Martens to a “sector perform” rating and decreased their price target for the stock from GBX 230 ($2.92) to GBX 180 ($2.28) in a report on Tuesday, May 30th.

Get Our Latest Report on DOCS

Dr. Martens Company Profile

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Featured Stories

• Five stocks we like better than Dr. Martens
• How to Invest in Tech Stocks and Top Tech Stocks to Consider
• 3 Sizzling Dividends That Are Going On Sale
• The “How” and “Why” of Investing in 5G Stocks
• 3 Ways To Trade, Trade Desk Stock Post Earnings
• EV Stocks and How to Profit from Them
• Inflation, The Fed, and Oil Prices: Interest Rates Are Going Up

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.